Lamotrigine may also have neuroprotective potential and we are interested in studying it in this manner. We have finished an open study in adolescents with bipolar depression (Chang et al., 2006) and have a few articles in review regarding the effects of lamotrigine on brain chemistry and function in this population. Note that these subjects were not all bipolar offspring, but a few were. Also, all subjects had bipolar I, II, or NOS.
And in the interest of further disclosure, I consult to Abbott and GSK and have received research funding from these companies. (GSK makes Lamictal (lamotrigine)). I also consult to AstraZeneca, Shire, and Lilly.
]]>